Skip to content
Yog Pharma
Metabolic and endocrineThiazolidinedione (PPAR-gamma agonist)

Pioglitazone Hydrochloride is a thiazolidinedione (PPAR-gamma agonist) indicated for type 2 diabetes mellitus. We supply it to US manufacturers of tablets and fixed-dose combinations.

CAS112529-15-4392.9 g/molC19H21ClN2O3S
2D structure of Pioglitazone Hydrochloride, shown as the active moiety without counter-ion or water of hydration.

Data from PubChem (CID 60560) and FDA’s substance registry

CAS number

112529-15-4

Molecular formula

C19H21ClN2O3S

Molecular weight

392.9g/mol

FDA UNII

IUPAC name

5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydrochloride

InChIKey

GHUUBYQTCDQWRA-UHFFFAOYSA-N

Appearance
Off-white to pale yellow powder.
Solubility
Practically insoluble in water. Soluble in dimethylformamide, slightly soluble in anhydrous ethanol, and very slightly soluble in acetone and acetonitrile.

Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.

Worth settling with your inquiry

Strengths are expressed as pioglitazone base: 16.53 mg of the hydrochloride delivers 15 mg.

On the US market

Reference product
ActosNDA 021073
Approved ANDAs
11 with a marketed product
Approved forms and strengths
  • Tablet 15 mg, 30 mg, 45 mg

Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. Strengths of salt forms are stated as the active moiety. The brand name belongs to its owner and identifies the reference product only.

Grade

USP or Ph. Eur. where a monograph exists, or your own specification.

Quantities

From development quantities for formulation work to commercial supply.

Packaging

To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.

Regulatory filings

US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.

Documents available with a quote

  • Specification and certificate of analysis
  • Safety data sheet
  • Method of analysis
  • DMF letter of authorization, where a US DMF is filed
  • GMP certificate and inspection history of the site
  • Residual solvents and elemental impurities statements
  • Nitrosamine risk assessment
  • TSE/BSE statement

Need something else for your QA file? Email info@yogpharma.com